PFM Health Sciences, LP
Position in AMLX — Amylyx Pharmaceuticals, Inc.
CIK 1442756
SAN FRANCISCO, CA
Position in AMLX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,019,322
+$393,971 QoQ
Shares Held
145,275
+8.0% QoQ
Ownership
0.131%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in AMLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026PFM Health Sciences, LP holds $83,113,221 across 5 Drug Manufacturers - Specialty & Generic names. AMLX ranks #5 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
215,678 | $28,413,419 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
39,805 | $23,603,568 | |
| 3 | INDV |
Indivior Pharmaceuticals, Inc.
|
574,666 | $17,515,819 | |
| 4 | AMRX |
Amneal Pharmaceuticals, Inc.
|
930,096 | $11,561,093 | |
| 5 | AMLX |
Amylyx Pharmaceuticals, Inc.
This page
|
145,275 | $2,019,322 |
All Filings in AMLX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,019,322 | 145,275 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,625,351 | 134,549 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $5,927,360 | 436,156 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $4,693,760 | 732,256 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,952,837 | 834,135 | Shares | Defined | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||